Neutropenia-Associated Outcomes in Adults with Acute Myeloid Leukemia Receiving Cytarabine Consolidation Chemotherapy with or without Granulocyte Colony-Stimulating Factor-Reference-Cited by-同舟云学术

Neutropenia-Associated Outcomes in Adults with Acute Myeloid Leukemia Receiving Cytarabine Consolidation Chemotherapy with or without Granulocyte Colony-Stimulating Factor

Published:2012-12 Issue:12 Volume:32 Page:1070-1077
ISSN:0277-0008
Container-title:Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
language:en
Short-container-title:Pharmacotherapy

Author:

Bradley Amber M.¹,Deal Allison M.²,Buie Larry W.³,van Deventer Hendrik

Affiliation:

1. Department of Clinical and Administrative Pharmacy; University of Georgia College of Pharmacy; Augusta; Georgia

2. University of North Carolina Lineberger Comprehensive Cancer Center; Chapel Hill; North Carolina

3. Department of Pharmacy; University of North Carolina Health Care; Chapel Hill; North Carolina

Publisher

Wiley

Subject

Pharmacology (medical)

Reference21 articles.

1. National Comprehensive Cancer Network Guideline: prevention and treatment of cancer-related infections 2011 http://www.nccn.org/professionals/physician_gls/pdf/infections.pdf

2. Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia;Body;Ann Intern Med,1966

3. 2006 Update of recommendations for the use of white blood cell growth factors: an evidence-based clinical practice guideline;Smith;J Clin Oncol,2006

4. Phase I/II study of recombinant human granulocyte colony-stimulating factor in patients receiving intensive chemotherapy for small cell lung cancer;Bronchud;Br J Cancer,1987

5. A randomized, double-blind, placebo-controlled, phase III study of filgrastim in remission induction and consolidation therapy for adults with de novo acute myeloid leukemia;Heil;Blood,1997

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effectiveness and safety of primary prophylaxis with G-CSF after induction therapy for acute myeloid leukemia: a systematic review and meta-analysis of the clinical practice guidelines for the use of G-CSF 2022 from the Japan society of clinical oncology;International Journal of Clinical Oncology;2024-03-18

2. EVALUATION OF USING EMPIRIC GLYCOPEPTIDES IN ACCORDANCE WITH THE IDSA GUIDELINE IN HEMATOLOGIC MALIGNANCY PATIENTS WITH FEBRILE NEUTROPENIA;Mediterranean Journal of Hematology and Infectious Diseases;2022-04-28

3. Efficacy and Safety of Filgrastim and Its Biosimilars to Prevent Febrile Neutropenia in Cancer Patients: A Prospective Study and Meta-Analysis;Biology;2021-10-19

4. Use of prophylactic pegfilgrastim for chemotherapy-induced neutropenia in the US: A review of adherence to present guidelines for usage;Cancer Treatment and Research Communications;2021

5. Use and effectiveness of pegfilgrastim prophylaxis in US clinical practice:a retrospective observational study;BMC Cancer;2019-08-09